Ointment for conditioning perimenopausal syndromes and preparation method thereof

Abstract

The invention provides an ointment for conditioning perimenopausal syndromes; the ointment is prepared from the following raw materials in parts by weight: 10-20 parts of donkey hide gelatin, 10-20 parts of a tortoise-shell glue, 5-10 parts of Chinese yam, 5-10 parts of Chinese wolfberry, 5-10 parts of mulberry, 5-8 parts of radix puerariae, 5-10 parts of rhizoma polygonati, 3-5 parts of cortex cinnamomi, 5-10 parts of poria cocos, 8-12 parts of semen ziziphi spinosae, 8-12 parts of rhizoma anemarrhenae, 8-12 parts of liquorice, 10-40 parts of walnut kernels, 10-40 parts of black sesame, 10-20 parts of rock sugar, and 20-60 parts of yellow rice wine. The ointment provided by the invention can effectively condition perimenopausal mental and physical states, and improves hectic fever, sweating, heart palpitations, chest distress, waist and neck aching pain, anxiety and other symptoms through blood replenishing and other conditioning.

Description

technical field [0001] The invention relates to the field of medicine and health care, in particular to an ointment for conditioning perimenopausal syndrome and a preparation method thereof. Background technique [0002] Perimenopause refers to a period of time before and after menopause in women, starting from about 45 years old to within 12 months after menopause, including from the endocrine, biological and clinical features related to menopause appearing near menopause to after the last menstrual period 1 year, which is the sign of ovarian function decline, lasts until 1 year after the last menstrual period, which is a period of normal physiological changes. [0003] However, due to the decline of ovarian function and the decline of estrogen levels in women during perimenopause, a series of symptoms such as hot flashes, sweating, palpitations, chest tightness, waist and neck pain, anxiety, etc. For "perimenopause syndrome". In the year of women's menopause, the kidney ...

AI Technical Summary

Problems solved by technology

[0004] At present, Western medicine adopts hormone replacement therapy to improve perimenopausal symptoms by supplementing exogenous estrogen and progesterone. However, in recent years, clinical trials of hormone replacement therapy in the United States have shown that continuous combined increases in heart disease events, stroke, breast cancer and risk of pulmonary embolism